Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FATE |
---|---|---|
09:32 ET | 18608 | 2.455 |
09:34 ET | 494 | 2.45 |
09:36 ET | 999 | 2.41 |
09:38 ET | 500 | 2.41 |
09:39 ET | 2217 | 2.4194 |
09:41 ET | 768 | 2.415 |
09:43 ET | 2050 | 2.415 |
09:45 ET | 4100 | 2.415 |
09:48 ET | 1208 | 2.405 |
09:50 ET | 2726 | 2.395 |
09:52 ET | 4195 | 2.405 |
09:54 ET | 3874 | 2.395 |
09:56 ET | 1300 | 2.41 |
09:57 ET | 4055 | 2.405 |
09:59 ET | 1332 | 2.395 |
10:01 ET | 3800 | 2.395 |
10:03 ET | 2989 | 2.395 |
10:06 ET | 400 | 2.395 |
10:08 ET | 2100 | 2.395 |
10:10 ET | 900 | 2.4 |
10:12 ET | 2400 | 2.415 |
10:14 ET | 2921 | 2.415 |
10:15 ET | 942 | 2.42 |
10:17 ET | 400 | 2.415 |
10:19 ET | 2998 | 2.44 |
10:21 ET | 2252 | 2.445 |
10:24 ET | 1300 | 2.45 |
10:26 ET | 3000 | 2.445 |
10:28 ET | 200 | 2.445 |
10:30 ET | 2435 | 2.435 |
10:32 ET | 600 | 2.435 |
10:33 ET | 2440 | 2.445 |
10:35 ET | 1600 | 2.43 |
10:37 ET | 4008 | 2.415 |
10:39 ET | 400 | 2.415 |
10:42 ET | 54730 | 2.4 |
10:44 ET | 4144 | 2.41 |
10:46 ET | 3558 | 2.4007 |
10:48 ET | 3276 | 2.4108 |
10:50 ET | 8708 | 2.405 |
10:51 ET | 1352 | 2.4046 |
10:53 ET | 11156 | 2.39 |
10:55 ET | 3150 | 2.4 |
10:57 ET | 841 | 2.395 |
11:00 ET | 1519 | 2.385 |
11:02 ET | 100 | 2.385 |
11:06 ET | 2189 | 2.385 |
11:08 ET | 1617 | 2.385 |
11:09 ET | 12057 | 2.371 |
11:11 ET | 4205 | 2.38 |
11:13 ET | 322 | 2.385 |
11:15 ET | 300 | 2.385 |
11:18 ET | 198 | 2.39 |
11:20 ET | 2000 | 2.4 |
11:22 ET | 2060 | 2.4 |
11:24 ET | 1248 | 2.3995 |
11:26 ET | 14608 | 2.395 |
11:27 ET | 11169 | 2.385 |
11:29 ET | 5379 | 2.395 |
11:31 ET | 3554 | 2.385 |
11:33 ET | 500 | 2.385 |
11:36 ET | 1565 | 2.385 |
11:38 ET | 2200 | 2.395 |
11:40 ET | 791 | 2.4 |
11:42 ET | 598 | 2.41 |
11:44 ET | 300 | 2.405 |
11:45 ET | 800 | 2.41 |
11:47 ET | 1000 | 2.405 |
11:49 ET | 200 | 2.405 |
11:51 ET | 100 | 2.405 |
11:54 ET | 1235 | 2.405 |
11:56 ET | 720 | 2.41 |
11:58 ET | 9974 | 2.395 |
12:00 ET | 1032 | 2.395 |
12:02 ET | 300 | 2.395 |
12:03 ET | 22076 | 2.38 |
12:05 ET | 10097 | 2.38 |
12:07 ET | 1947 | 2.375 |
12:09 ET | 200 | 2.375 |
12:12 ET | 9143 | 2.365 |
12:14 ET | 8442 | 2.375 |
12:16 ET | 1100 | 2.375 |
12:18 ET | 800 | 2.375 |
12:20 ET | 15020 | 2.355 |
12:21 ET | 13508 | 2.37 |
12:23 ET | 18549 | 2.385 |
12:25 ET | 18421 | 2.395 |
12:27 ET | 100 | 2.395 |
12:30 ET | 2046 | 2.395 |
12:32 ET | 652 | 2.4 |
12:34 ET | 6928 | 2.395 |
12:36 ET | 318 | 2.395 |
12:38 ET | 47253 | 2.385 |
12:39 ET | 5706 | 2.385 |
12:41 ET | 1192 | 2.385 |
12:43 ET | 800 | 2.385 |
12:45 ET | 90976 | 2.385 |
12:48 ET | 2300 | 2.385 |
12:50 ET | 8669 | 2.3788 |
12:52 ET | 500 | 2.37 |
12:54 ET | 600 | 2.37 |
12:56 ET | 900 | 2.375 |
12:57 ET | 300 | 2.375 |
12:59 ET | 2255 | 2.37 |
01:01 ET | 20118 | 2.385 |
01:03 ET | 2494 | 2.3851 |
01:06 ET | 3200 | 2.385 |
01:08 ET | 1708 | 2.38 |
01:10 ET | 10435 | 2.375 |
01:12 ET | 7162 | 2.385 |
01:14 ET | 516 | 2.385 |
01:15 ET | 200 | 2.385 |
01:17 ET | 10319 | 2.395 |
01:19 ET | 2761 | 2.395 |
01:21 ET | 2131 | 2.4 |
01:24 ET | 1098 | 2.395 |
01:26 ET | 5350 | 2.385 |
01:28 ET | 1901 | 2.385 |
01:30 ET | 2888 | 2.37 |
01:32 ET | 100 | 2.37 |
01:33 ET | 12112 | 2.37 |
01:35 ET | 512 | 2.375 |
01:39 ET | 800 | 2.375 |
01:42 ET | 600 | 2.375 |
01:44 ET | 300 | 2.375 |
01:46 ET | 464 | 2.375 |
01:48 ET | 4062 | 2.365 |
01:50 ET | 855 | 2.36 |
01:51 ET | 51676 | 2.355 |
01:53 ET | 311 | 2.355 |
01:55 ET | 2012 | 2.355 |
01:57 ET | 1548 | 2.35 |
02:00 ET | 2000 | 2.355 |
02:02 ET | 14618 | 2.355 |
02:04 ET | 1856 | 2.355 |
02:06 ET | 1350 | 2.355 |
02:08 ET | 1300 | 2.355 |
02:09 ET | 300 | 2.355 |
02:11 ET | 2700 | 2.355 |
02:13 ET | 14167 | 2.34 |
02:15 ET | 2901 | 2.345 |
02:18 ET | 4024 | 2.335 |
02:20 ET | 6301 | 2.325 |
02:22 ET | 11585 | 2.31 |
02:24 ET | 31555 | 2.295 |
02:26 ET | 107886 | 2.3 |
02:27 ET | 8077 | 2.295 |
02:29 ET | 1996 | 2.295 |
02:31 ET | 20670 | 2.295 |
02:33 ET | 7148 | 2.295 |
02:36 ET | 1634 | 2.295 |
02:38 ET | 6932 | 2.271 |
02:40 ET | 13003 | 2.285 |
02:42 ET | 6033 | 2.29 |
02:44 ET | 2244 | 2.285 |
02:45 ET | 1629 | 2.285 |
02:47 ET | 1429 | 2.285 |
02:49 ET | 1761 | 2.285 |
02:51 ET | 526 | 2.285 |
02:54 ET | 1766 | 2.285 |
02:56 ET | 14495 | 2.285 |
02:58 ET | 5979 | 2.29 |
03:00 ET | 6353 | 2.29 |
03:02 ET | 2676 | 2.29 |
03:03 ET | 1372 | 2.29 |
03:05 ET | 4215 | 2.285 |
03:07 ET | 5499 | 2.295 |
03:09 ET | 5060 | 2.305 |
03:12 ET | 1382 | 2.305 |
03:14 ET | 13735 | 2.305 |
03:16 ET | 2013 | 2.3 |
03:18 ET | 3807 | 2.305 |
03:20 ET | 1108 | 2.3 |
03:21 ET | 978 | 2.31 |
03:23 ET | 30774 | 2.3 |
03:25 ET | 9502 | 2.305 |
03:27 ET | 1900 | 2.3 |
03:30 ET | 28062 | 2.315 |
03:32 ET | 18211 | 2.335 |
03:34 ET | 9541 | 2.345 |
03:36 ET | 3045 | 2.34 |
03:38 ET | 41331 | 2.325 |
03:39 ET | 400 | 2.325 |
03:41 ET | 15512 | 2.325 |
03:43 ET | 1164 | 2.325 |
03:45 ET | 93812 | 2.345 |
03:48 ET | 3650 | 2.35 |
03:50 ET | 4296 | 2.355 |
03:52 ET | 23029 | 2.36 |
03:54 ET | 21901 | 2.35 |
03:56 ET | 18462 | 2.365 |
03:57 ET | 21448 | 2.365 |
03:59 ET | 223448 | 2.37 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fate Therapeutics Inc | 283.6M | -1.4x | --- |
ADC Therapeutics SA | 285.2M | -1.1x | --- |
Poseida Therapeutics Inc | 231.1M | -2.0x | --- |
Personalis Inc | 294.3M | -3.1x | --- |
AVITA Medical Inc | 270.0M | -5.2x | --- |
Codexis Inc | 227.7M | -2.9x | --- |
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $283.6M |
---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 113.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.85 |
EPS | $-1.71 |
Book Value | $3.74 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 23.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,587.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.